Published: July 13, 2011
Gold Standard Diagnostics Signs U.S. Distribution Agreement With Fujirebio Diagnostics for Multi-Constituent Tumor Marker Control
DAVIS, Calif. - (BUSINESS WIRE) - Gold Standard Diagnostics, Corp., (GSD) http://www.gsdx.us/
a leading supplier of products and services to the medical diagnostic
industry, today announced the execution of an agreement with Fujirebio
Diagnostics to distribute their proprietary Multi-Constituent Tumor
Marker Control in the United States. Fujirebio Diagnostics, best
known in the U.S. market as the developers of the CA125 ovarian
cancer marker, has several patents on biomarkers for various disease
states, but is primarily focused on oncology markers.
Multi-Constituent Control
The Fujirebio Diagnostics Tumor Marker Control allows
laboratories to monitor the precision and accuracy of assays used in the
monitoring of progression and response to treatment for various cancers.
The Tumor Marker Control includes AFP, CEA, Total-PSA, Free-PSA,
CA125, CA19-9, CA15-3, CA27.29, CA242, Ferritin and is the
only multi-constituent control to contain the proprietary marker HE4.
In order to provide a control that closely resembles a patient sample,
the control has been developed with a 100% human serum matrix,
improved stability and clinically relevant proportions of Free-PSA
and PSA-ACT (to assess performance of a Total PSA assay). In
addition, the target values have been established at medically relevant
analyte levels to ensure precision and accuracy around medical decision
points.
About Fujirebio Diagnostics, Inc.
Fujirebio Diagnostics is the premier cancer diagnostics company and the
industry leader in cancer biomarker assays. Fujirebio Diagnostics
specializes in the clinical development, manufacturing and
commercialization of in-vitro diagnostic products for the management of
human disease states, with an emphasis in oncology. Fujirebio
Diagnostics is one of the group companies of Miraca Holdings, Inc., in
Japan, set up in July 2005 to combine Fujirebio Inc., the leading
in-vitro diagnostics company, and SRL, Inc., the top provider of
clinical laboratory testing services in Japan. Fujirebio Diagnostics has
a worldwide distribution network which enables physicians and patients
to access its diagnostic products.
About Gold Standard Diagnostics
Gold Standard Diagnostics is Davis, California based sales, marketing,
and distribution company, who partners with reagent and equipment
manufacturers from around the world, creating innovative and cost
effective diagnostics solutions for clinical and hospital laboratories.
GSD also develops its own suite of proprietary products, including the
recently launched Thunderbolt platform, which provide laboratories the
next wave of technology-based solutions. For more information please
call 530-759-8000 or visit www.gsdx.us.
for Gold Standard Diagnostics
Cheryl Cink, +1-530-219-3949
ccink@syncpr.com
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News
Search News
